sj-pdf-1-trd-10.1177_26330040221093743 – Supplemental material for Quality of life in Barth syndrome [PDF]
, 2022 Supplemental material, sj-pdf-1-trd-10.1177_26330040221093743 for Quality of life in Barth syndrome by Alexander Y. Kim, Hilary Vernon, Ryan Manuel, Mohammed Almuqbil and Brittany Hornby in Therapeutic Advances in Rare ...
Alexander Y. Kim (4408057) +4 more
core +1 more source
sj-docx-1-trd-10.1177_26330040231164425 – Supplemental material for Emerging roles and opportunities for rare disease patient advocacy groups [PDF]
, 2023 Supplemental material, sj-docx-1-trd-10.1177_26330040231164425 for Emerging roles and opportunities for rare disease patient advocacy groups by Amy M. Patterson, Megan O’Boyle, Grace E. VanNoy and Kira A.
Kira A. Dies (12282032) +3 more
core +1 more source
sj-pdf-1-trd-10.1177_26330040221139872 – Supplemental material for Clinical evidence of interventions assessed in Friedreich ataxia: a systematic review [PDF]
, 2022 Supplemental material, sj-pdf-1-trd-10.1177_26330040221139872 for Clinical evidence of interventions assessed in Friedreich ataxia: a systematic review by Paridhi Jain, Lohit Badgujar, Jelle Spoorendonk and Katharina Buesch in Therapeutic Advances in ...
Lohit Badgujar (14198560) +3 more
core +1 more source
Triggering with the ALICE TRD [PDF]
Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 2013 6 pages, 10 ...
Dietel, T. +8 more
openaire +4 more sources
BJPsych Open, 2023 Background Previous studies have not investigated response rates after electroconvulsive therapy (ECT) in patients with non-psychotic treatment-resistant depression (TRD). Aims To assess and compare the response rate of ECT for patients with TRD and non-
Adam Nygren +5 more
doaj +1 more source
sj-doc-1-trd-10.1177_26330040231158776 – Supplemental material for A novel case of homozygous PAX1 mutation associated with hypoparathyroidism [PDF]
, 2023 Supplemental material, sj-doc-1-trd-10.1177_26330040231158776 for A novel case of homozygous PAX1 mutation associated with hypoparathyroidism by Benjamin L. Hamel, Seema Kumar, Leah Heidenreich, Avni Joshi, Christiana DaSilva and Faizal Z.
Avni Joshi (14778411) +5 more
core +1 more source
Characterising the severity of treatment resistance in unipolar and bipolar depression
BJPsych Open, 2021 Background Treatment-resistant depression (TRD) is classically defined according to the number of suboptimal antidepressant responses experienced, but multidimensional assessments of TRD are emerging and may confer some advantages.
Rachael W. Taylor +4 more
doaj +1 more source
sj-docx-1-trd-10.1177_26330040231191141 – Supplemental material for Case report on the use of canakinumab for treatment of recurrent fevers and proteinuria in refractory systemic lupus erythematosus [PDF]
, 2023 Supplemental material, sj-docx-1-trd-10.1177_26330040231191141 for Case report on the use of canakinumab for treatment of recurrent fevers and proteinuria in refractory systemic lupus erythematosus by Kimia Yavari and Joseph Grisanti in Therapeutic ...
Joseph Grisanti (16912513) +1 more
core +1 more source
Striatal dopamine D2/3 receptor availability in treatment resistant depression. [PDF]
PLoS ONE, 2014 Several studies demonstrated improvement of depressive symptoms in treatment resistant depression (TRD) after administering dopamine agonists which suggest abnormal dopaminergic neurotransmission in TRD.
Bart P de Kwaasteniet +5 more
doaj +1 more source
sj-xlsx-1-trd-10.1177_26330040221076497 – Supplemental material for A Systematic Review investigating the Effectiveness of Exercise training in Glycogen Storage Diseases [PDF]
, 2022 Supplemental material, sj-xlsx-1-trd-10.1177_26330040221076497 for A Systematic Review investigating the Effectiveness of Exercise training in Glycogen Storage Diseases by Claire Bordoli, Elaine Murphy, Ian Varley, Graham Sharpe and Philip Hennis in ...
Claire Bordoli (12027828) +4 more
core +1 more source